Jin Medical International Ltd. (ZJYL) Earnings History
Steady Earner8 years of earnings data (2018–2025) · Positive but moderate multi-year EPS trajectory
Loading earnings history...
Jin Medical International Ltd. (ZJYL) Earnings Overview
As of June 23, 2026, Jin Medical International Ltd. (ZJYL) reported trailing twelve-month net income of $5M, reflecting -68.1% year-over-year growth. The company earned $0.62 per diluted share over the past four quarters, with a net profit margin of 5.8%.
Looking at the long-term picture, ZJYL's 5-year EPS compound annual growth rate (CAGR) stands at +6.4%, showing solid earnings momentum. The company achieved its highest annual net income of $4M in fiscal 2018.
Jin Medical International Ltd. maintains positive profitability with a gross margin of 29.2%, operating margin of 2.9%, and net margin of 5.8%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including MPWR ($616M net income, 22.1% margin), NVCR (-$173M net income, -20.8% margin), LFUS (-$40M net income, -3.0% margin), ZJYL has room to improve margins relative to the peer group. Compare ZJYL vs MPWR →
ZJYL Earnings vs Peers
Earnings metrics vs comparable public companies
ZJYL Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1M | -67.6% | $608,182 | $0.15 | 5.8% | 2.9% |
| 2024 | $4M | +27.7% | $4M | $0.47 | 15.6% | 15.5% |
| 2023 | $3M | +6.3% | $3M | $0.40 | 14.5% | 14.5% |
| 2022 | $3M | +2.8% | $2M | $0.40 | 14.1% | 11.1% |
| 2021 | $3M | +19.3% | $3M | $0.20 | 12.7% | 12.7% |
| 2020 | $2M | -39.5% | $2M | $0.11 | 13.6% | 14.5% |
| 2019 | $4M | -0.9% | $4M | $0.18 | 17.9% | 21.6% |
| 2018 | $4M | - | $4M | $0.18 | 17.6% | 20.2% |
Download Data
Export ZJYL earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ZJYL — Frequently Asked Questions
Quick answers to the most common questions about buying ZJYL stock.
What is ZJYL earnings per share (EPS)?
ZJYL trailing twelve-month (TTM) diluted EPS is $0.62, reflecting -68.1% year-over-year growth. The 5-year EPS CAGR is +6.4%. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Jin Medical International Ltd.'s net income?
Jin Medical International Ltd. (ZJYL) trailing twelve-month net income is $5M as of 2025. Earnings declined -68.1% year-over-year. Jin Medical International Ltd. has been profitable for 8 consecutive years.
Is ZJYL profitable?
Yes, ZJYL is profitable with a TTM net income of $5M and a net profit margin of +5.8%. Jin Medical International Ltd. has generated profits for 8 consecutive years.
What is ZJYL's earnings growth rate?
ZJYL compound annual EPS growth rates (CAGR): 1-Year: -68.1%, 3-Year: -27.9%, 5-Year: +6.4%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are ZJYL's profit margins?
Jin Medical International Ltd. net profit margin is +5.8%, operating margin is +2.9%, and gross margin is +29.2%. Margins are within a typical range for the sector. Return on Equity is +4.1%.
Is ZJYL growing earnings?
ZJYL earnings are declining — EPS fell -68.1% year-over-year. TTM net income dropped to $5M. This contrasts with the 5-year CAGR of +6.4%.
What was ZJYL's best earnings year?
Jin Medical International Ltd.'s highest annual net income on record is $4M, achieved in fiscal year 2018. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were ZJYL's earnings last quarter?
ZJYL's most recent reported quarter was Q4 2025. Net income was $1M with diluted EPS of $0.16. For a full breakdown of all quarters, see the quarterly earnings table on this page.